While this happened, Maxim Group initiated its Citius Pharmaceuticals Inc [CTXR] rating to a Buy in a research note published on November 30, 2021; the price target was $4.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
Price Performance Review of CTXR
On Tuesday, Citius Pharmaceuticals Inc [NASDAQ:CTXR] saw its stock fall -14.45% to $0.19. Over the last five days, the stock has lost -60.22%. Citius Pharmaceuticals Inc shares have fallen nearly -74.65% since the year began. Nevertheless, the stocks have fallen -75.18% over the past one year. While a 52-week high of $1.07 was reached on 04/02/24, a 52-week low of $0.19 was recorded on 11/15/24. SMA at 50 days reached $0.4174, while 200 days put it at $0.6465.
Levels Of Support And Resistance For CTXR Stock
The 24-hour chart illustrates a support level at 0.1777, which if violated will result in even more drops to 0.1635. On the upside, there is a resistance level at 0.2175. A further resistance level may holdings at 0.2431. The Relative Strength Index (RSI) on the 14-day chart is 30.44, which indicates neutral technical sentiment, while the Moving Average Convergence Divergence (MACD) stands at -0.1399, which suggests price will go down in the next trading period. Percent R suggests that price movement has been bearish at 98.68%. Stochastics %K at 5.47% indicates the stock is a buying.
How much short interest is there in Citius Pharmaceuticals Inc?
A steep rise in short interest was recorded in Citius Pharmaceuticals Inc stocks on 2024-10-31, dropping by -0.98 million shares to a total of 11.79 million shares. Yahoo Finance data shows the prior-month short interest on 2024-09-30 was 12.77 million shares. There was a decline of -8.32%, which implies that there is a negative sentiment for the stock.
